On the evening of June 14, the Hong Kong Stock Exchange-listed company Smoore International (06969.HK) issued a statement. It stated that on June 21, 2024, one of the group's clients, NJOY LLC (a wholly-owned subsidiary of Altria Group), has received marketing authorization orders (MGO) for four new tobacco products (including two menthol-flavored closed pod electronic cigarettes (NJOY ACE Pod Menthol 2.4%, NJOY ACE Pod Menthol 5%) and two menthol-flavored disposable e-cigarettes (NJOY DAILY Menthol 4.5%, NJOY DAILY EXTRA Menthol 6%)) through the pre-market tobacco product application (PMTA) pathway.
Smoore International announced that as of the date of this announcement, the company's client NJOY LLC has received marketing approvals for ten new tobacco products through the pre-market pathway, including a NJOY ACE closed-system e-cigarette device, five NJOY ACE tobacco and menthol flavored closed-system electronic pods, and four NJOY DAILY tobacco and menthol flavored disposable e-cigarettes. Based on sales records from the beginning of the year to the date of this announcement, the company has supplied these ten products to NJOY LLC.
It is worth noting that on the first trading day after the FDA announcement, Smoore International opened higher in early trading and surged over 12% at one point. As of the time of writing, the stock is currently trading at 10.04 Hong Kong dollars.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
